Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain

BACKGROUND: The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including best supportive care, low dose chemotherapy and standard dose chemotherapy. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Crespo, Carlos, Moreno, Estela, Sierra, Jordi, Serip, Suzan, Rubio, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029489/
https://www.ncbi.nlm.nih.gov/pubmed/24314138
http://dx.doi.org/10.1186/2191-1991-3-28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029489/
https://www.ncbi.nlm.nih.gov/pubmed/24314138
http://dx.doi.org/10.1186/2191-1991-3-28

Ejemplares similares